AMGN - AMGEN Inc.
IEX Last Trade
333.93
2.920 0.874%
Share volume: 2,173,358
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$331.01
2.92
0.88%
Fundamental analysis
30%
Profitability
54%
Dept financing
25%
Liquidity
29%
Performance
8%
Performance
5 Days
1.53%
1 Month
1.56%
3 Months
12.46%
6 Months
23.74%
1 Year
37.36%
2 Year
53.12%
Key data
Stock price
$333.93
DAY RANGE
$330.22 - N/A
52 WEEK RANGE
$234.09 - $342.07
52 WEEK CHANGE
$0.38
DIVIDEND
$2.25
EX-DIVIDEND DATE
08/16/2024
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Robert Bradway
Region: US
Website: https://www.amgen.com/
Employees: 25,200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.amgen.com/
Employees: 25,200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
Recent news